Showing 241 - 260 results of 10,572 for search '"Tumor"', query time: 0.09s Refine Results
  1. 241

    A Pleural Solitary Fibrous Tumor, Multiple Gastrointestinal Stromal Tumors, Moyamoya Disease, and Hyperparathyroidism in a Patient Associated with NF1 by Yoko Yamamoto, Ken Kodama, Shigekazu Yokoyama, Masashi Takeda, Shintaro Michishita

    Published 2015-01-01
    “…Loss of the gene function, due to a point mutation, leads to an increase in cell proliferation and the development of several tumors. We report a 60-year-old female patient manifesting hypercalcemia due to hyperparathyroidism, a solitary fibrous tumor (SFT) of the pleura, multiple gastrointestinal stromal tumors (GISTs), and moyamoya disease associated with NF1. …”
    Get full text
    Article
  2. 242
  3. 243

    Comprehensive single-cell atlas of colorectal neuroendocrine tumors with liver metastases: unraveling tumor microenvironment heterogeneity between primary lesions and metastases by Yiqiao Deng, Qichen Chen, Chengyao Guo, Jinghua Chen, Xin Li, Zhiyu Li, Yefan Zhang, Jianjun Zhao, Jianguo Zhou, Jianqiang Cai, Tao Yan, Xiaobing Wang, Xinyu Bi, Zhen Huang, Hong Zhao

    Published 2025-01-01
    “…Abstract Background Colorectal neuroendocrine tumors with liver metastases (CRNELM) are associated with a poorer prognosis compared to their nonmetastatic counterparts. …”
    Get full text
    Article
  4. 244

    CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment by Yu Wang, Haiyan Xu, Li Cai, Yang Sun, Liwei Wang, Ming Yue, Xiaofei Zhang, Yanling Wang, Shumin Li, Shengbai Xue, Jingyu Ma, Tiebo Mao, Weiyu Ge, Daiyuan Shentu, Wenxin Lu, Yongchao Wang, Jiong Hu, Jiujie Cui

    Published 2025-01-01
    “…Clinically, CREB3L1 correlated with immune cell signatures as well as immune checkpoint blockade (ICB) treatment response and outcome that CREB3L1aberrant activation indicated poorer efficacy and worse prognosis than the low in PDAC which might empower clinical decision.Conclusions Collectively, this study revealed CREB3L1 facilitated PDAC progression, shaped an immune exclude tumor microenvironment and distinguished therapy response and outcome of ICB therapy indicating CREB3L1 could be a promising novel molecular target and biomarker for PDAC treatment.…”
    Get full text
    Article
  5. 245
  6. 246
  7. 247
  8. 248
  9. 249

    Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells by Kinga Wilkus-Adamczyk, Klaudia Brodaczewska, Claudine Kieda

    Published 2024-12-01
    “…The tumor suppressor PTEN regulates angiogenesis, a process involving endothelial cells (ECs). …”
    Get full text
    Article
  10. 250

    Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction by Francesco Verona, Sebastiano Di Bella, Roberto Schirano, Camilla Manfredi, Francesca Angeloro, Giulia Bozzari, Matilde Todaro, Matilde Todaro, Giuseppe Giannini, Giuseppe Giannini, Giorgio Stassi, Veronica Veschi

    Published 2025-02-01
    “…Cancer stem cells (CSCs) are a small subset within the tumor mass significantly contributing to cancer progression through dysregulation of various oncogenic pathways, driving tumor growth, chemoresistance and metastasis formation. …”
    Get full text
    Article
  11. 251
  12. 252
  13. 253

    Primary epithelioid trophoblastic tumor of the lung: A case report by Qiongying Zhang, Wenwen Sun, Zhen Zhang, Jianmin Li

    Published 2024-04-01
    Subjects: “…epithelioid trophoblastic tumor (ett)…”
    Get full text
    Article
  14. 254
  15. 255
  16. 256

    Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer by K. C. Masoumi, Gina Shaw-Hallgren, Ramin Massoumi

    Published 2011-01-01
    “…In basal cell carcinoma, the tumor suppressor protein CYLD is repressed at the transcriptional levels through hedgehog signaling pathway. …”
    Get full text
    Article
  17. 257
  18. 258

    Breast Neuroendocrine Tumor. Case Report and Literature Review by Lidia Torres Aja

    Published 2017-04-01
    “…Primary neuroendocrine carcinomas of the breast are rare neoplasms, accounting for 2 to 5 % of breast tumors. For their diagnosis it is required that more than 50 % of the tumor present neuroendocrine features. …”
    Get full text
    Article
  19. 259
  20. 260

    Active Roles of Tumor Stroma in Breast Cancer Metastasis by Zahraa I. Khamis, Ziad J. Sahab, Qing-Xiang Amy Sang

    Published 2012-01-01
    “…Metastasis is the major cause of death for breast cancer patients. Tumors are heterogenous cellular entities composed of cancer cells and cells of the microenvironment in which they reside. …”
    Get full text
    Article